Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells.
Shapira S, Finkelshtein E, Kazanov D, Naftali E, Stepansky I, Loyter A, Elbirt D, Hay-Levy M, Brazowski E, Bedny F, Dekel R, Hershkovitz D, Blachar A, Wolf I, Arber N. Shapira S, et al. Among authors: brazowski e. Oncogene. 2021 Jun;40(22):3815-3825. doi: 10.1038/s41388-021-01779-5. Epub 2021 May 6. Oncogene. 2021. PMID: 33958722 Free PMC article.
Rofecoxib reduces polyp recurrence in familial polyposis.
Hallak A, Alon-Baron L, Shamir R, Moshkowitz M, Bulvik B, Brazowski E, Halpern Z, Arber N. Hallak A, et al. Among authors: brazowski e. Dig Dis Sci. 2003 Oct;48(10):1998-2002. doi: 10.1023/a:1026130623186. Dig Dis Sci. 2003. PMID: 14627347 Clinical Trial.
Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.
Reichman H, Itan M, Rozenberg P, Yarmolovski T, Brazowski E, Varol C, Gluck N, Shapira S, Arber N, Qimron U, Karo-Atar D, Lee JJ, Munitz A. Reichman H, et al. Among authors: brazowski e. Cancer Immunol Res. 2019 Mar;7(3):388-400. doi: 10.1158/2326-6066.CIR-18-0494. Epub 2019 Jan 21. Cancer Immunol Res. 2019. PMID: 30665890
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.
Golan T, Barenboim A, Lahat G, Nachmany I, Goykhman Y, Shacham-Shmueli E, Halpern N, Brazowski E, Geva R, Wolf I, Goldes Y, Ben-Haim M, Klausner JM, Lubezky N. Golan T, et al. Among authors: brazowski e. Ann Surg Oncol. 2020 Oct;27(10):3963-3970. doi: 10.1245/s10434-020-08469-8. Epub 2020 Apr 20. Ann Surg Oncol. 2020. PMID: 32314163
74 results